1. Home
  2. COLL vs SBR Comparison

COLL vs SBR Comparison

Compare COLL & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • SBR
  • Stock Information
  • Founded
  • COLL 2002
  • SBR 1982
  • Country
  • COLL United States
  • SBR United States
  • Employees
  • COLL N/A
  • SBR N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • SBR Oil & Gas Production
  • Sector
  • COLL Health Care
  • SBR Energy
  • Exchange
  • COLL Nasdaq
  • SBR Nasdaq
  • Market Cap
  • COLL 958.8M
  • SBR 972.2M
  • IPO Year
  • COLL 2015
  • SBR N/A
  • Fundamental
  • Price
  • COLL $37.03
  • SBR $71.49
  • Analyst Decision
  • COLL Strong Buy
  • SBR
  • Analyst Count
  • COLL 4
  • SBR 0
  • Target Price
  • COLL $44.25
  • SBR N/A
  • AVG Volume (30 Days)
  • COLL 380.6K
  • SBR 33.4K
  • Earning Date
  • COLL 08-07-2025
  • SBR 01-01-0001
  • Dividend Yield
  • COLL N/A
  • SBR 7.66%
  • EPS Growth
  • COLL N/A
  • SBR N/A
  • EPS
  • COLL 1.06
  • SBR 5.05
  • Revenue
  • COLL $707,007,000.00
  • SBR $77,682,730.00
  • Revenue This Year
  • COLL $20.47
  • SBR N/A
  • Revenue Next Year
  • COLL $2.91
  • SBR N/A
  • P/E Ratio
  • COLL $35.07
  • SBR $14.20
  • Revenue Growth
  • COLL 22.61
  • SBR N/A
  • 52 Week Low
  • COLL $23.23
  • SBR $58.25
  • 52 Week High
  • COLL $42.29
  • SBR $72.60
  • Technical
  • Relative Strength Index (RSI)
  • COLL 69.53
  • SBR 70.91
  • Support Level
  • COLL $29.70
  • SBR $68.41
  • Resistance Level
  • COLL $38.24
  • SBR $71.40
  • Average True Range (ATR)
  • COLL 1.23
  • SBR 1.49
  • MACD
  • COLL 0.71
  • SBR 0.48
  • Stochastic Oscillator
  • COLL 87.29
  • SBR 80.70

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.

Share on Social Networks: